DV
Dividend Vision

MRNX — Defiance Daily Target 2X Long MRNA ETF

Defiance Daily Target 2X Long MRNA ETF (MRNX)

Total return is 55.3% over the past 0.5 years, 7.3 points ahead of MRNA at 48.0%.

Defiance Daily Target 2X Long MRNA ETF provides leveraged exposure to Moderna Inc. (MRNA) through a daily reset mechanism that aims to deliver twice the daily performance of the underlying stock. This is a specialized equity product designed for experienced traders seeking short-term directional bets on MRNA rather than long-term income generation, as it carries significant volatility and decay risk over extended holding periods and does not distribute dividends. The fund appeals primarily to sophisticated investors with high risk tolerance who trade actively and understand the mechanics and risks of leveraged ETFs.

MRNX key facts

Issuer
Defiance ETFs
Asset type
ETF
Asset class
Equity
Last close
$31.65
Average volume
66500.0